Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
Clinical trial NCT06828887 · RECRUITING
Trial details
- NCT number
- NCT06828887
- Sponsor
- Vigonvita Life Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-03
- Primary completion
- 2026-09-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.